Bayforest Capital Ltd Decreases Stock Position in Masimo Corporation $MASI

Bayforest Capital Ltd lessened its stake in shares of Masimo Corporation (NASDAQ:MASI) by 87.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 464 shares of the medical equipment provider’s stock after selling 3,095 shares during the period. Bayforest Capital Ltd’s holdings in Masimo were worth $60,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Masimo by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after buying an additional 66 shares during the period. Clearstead Advisors LLC raised its holdings in Masimo by 18.4% during the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73 shares during the period. Assetmark Inc. raised its holdings in Masimo by 5.5% during the 4th quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock valued at $241,000 after buying an additional 97 shares during the period. Orion Porfolio Solutions LLC grew its position in Masimo by 2.2% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock valued at $819,000 after acquiring an additional 104 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its position in Masimo by 80.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 136 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective on the stock. in a research report on Tuesday, February 17th. Finally, Wells Fargo & Company raised Masimo to a “hold” rating in a research report on Wednesday, March 18th. Eight research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $181.17.

Masimo Price Performance

Shares of MASI stock opened at $178.71 on Friday. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $179.00. The stock has a market capitalization of $9.60 billion, a price-to-earnings ratio of -16.96, a P/E/G ratio of 1.81 and a beta of 1.20. The stock has a fifty day simple moving average of $175.08 and a two-hundred day simple moving average of $152.88. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.